NACDS emphasized the need for Congress to address direct and indirect remuneration (DIR) fee relief as it considers solutions to reduce healthcare costs.
NACDS recommended several measures to lower prescription drug prices and improve patient health--including DIR fee relief--to the House Committee on Energy and Commerce Subcommittee on Health.
Saturday, April 27 marks the DEA's National Drug Take Back Day. In the lead-up to that event, the FDA just launched a drug safety campaign aimed at opioid abuse prevention.
NACDS signed on to a letter supporting the Restoring Access to Medications Act, which would allow Americans to use the funds in their healthcare accounts to purchase over-the-counter (OTC) medications.
Former Speaker of the House of Representatives Paul Ryan (R-WI), Pulitzer Prize-winning author Doris Kearns Goodwin and Former Senator Jeff Flake (R-AZ) are set to speak at the 2019 NACDS Annual Meeting, April 27-30.
Rep. Ami Bera (D-CA) recognized the importance of pharmacists as accessible healthcare providers during a Costco pharmacy tour as part of the NACDS RxIMPACT program.
NACDS Senior Vice President and General Counsel Don Bell was recently named the only association general counsel to the "GC Powerlist" by The Legal 500.
Members of Congress reported to their constituents on meetings they had during NACDS RxIMPACT Day on Capitol Hill on opioid abuse prevention and DIR fee reform.
NACDS and NCPA held a briefing this week on DIR fee reform for the Congressional Doctors Caucus. The Caucus is comprised of 16 medical providers in Congress who use their medical expertise to develop patient-centered healthcare policy.
Rep. Cathy McMorris Rodgers (R-WA), a consistently pro-pharmacy advocate, led a letter to Health and Human Services Secretary Alex Azar urging support for DIR fee reform.